Literature DB >> 21514424

Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.

Marijke Kamsteeg1, Mieke Bergers, Roelie de Boer, Patrick L J M Zeeuwen, Stanleyson V Hato, Joost Schalkwijk, Geuranne S Tjabringa.   

Abstract

Both the immune system and the epidermis likely have an important role in the pathogenesis of atopic dermatitis (AD). The objective of the present study was to develop a human skin equivalent model exhibiting morphologic and molecular characteristics of AD in a controlled manner. Skin equivalents generated from normal adult human keratinocytes were stimulated with type 2 T-helper cell (Th2) cytokines IL-4 and IL-13, and morphologic features and gene expression of the epidermis were studied. Th2 cytokines induced intercellular edema similar to spongiotic changes observed in lesional AD as assessed at histopathologic analysis and electron microscopy. Furthermore, genes known to be specifically expressed in epidermis of patients with AD such as CAII and NELL2 were induced. In contrast, expression of psoriasis-associated genes such as elafin and hBD2 was not changed. Th2 cytokines caused DNA fragmentation in the keratinocytes, which could be inhibited by the caspase inhibitor Z-VAD, which suggests that apoptosis was induced. In addition, up-regulation of the death receptor Fas was observed in keratinocytes after Th2 cytokine stimulation. IL-4 and IL-13 induced phosphorylation of the signaling molecule STAT6. It was concluded that the skin equivalent model described herein may be useful in investigation of the epidermal aspects of AD and for study of drugs that act at the level of keratinocyte biology.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514424      PMCID: PMC3081201          DOI: 10.1016/j.ajpath.2011.01.037

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Allergic and nonallergic forms of atopic diseases.

Authors:  Natalija Novak; Thomas Bieber
Journal:  J Allergy Clin Immunol       Date:  2003-08       Impact factor: 10.793

3.  Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.

Authors:  A Trautmann; M Akdis; P Schmid-Grendelmeier; R Disch; E B Bröcker; K Blaser; C A Akdis
Journal:  J Allergy Clin Immunol       Date:  2001-11       Impact factor: 10.793

Review 4.  Role of dysregulated apoptosis in atopic dermatitis.

Authors:  A Trautmann; M Akdis; K Blaser; C A Akdis
Journal:  Apoptosis       Date:  2000-11       Impact factor: 4.677

5.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

6.  Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase.

Authors:  P L Zeeuwen; I M Van Vlijmen-Willems; B J Jansen; G Sotiropoulou; J H Curfs; J F Meis; J J Janssen; F Van Ruissen; J Schalkwijk
Journal:  J Invest Dermatol       Date:  2001-05       Impact factor: 8.551

Review 7.  Atopic dermatitis.

Authors:  Donald Y M Leung; Thomas Bieber
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

8.  Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis.

Authors:  Ichiro Nomura; Bifeng Gao; Mark Boguniewicz; Marc A Darst; Jeffrey B Travers; Donald Y m Leung
Journal:  J Allergy Clin Immunol       Date:  2003-12       Impact factor: 10.793

9.  A neuron-specific EGF family protein, NELL2, promotes survival of neurons through mitogen-activated protein kinases.

Authors:  Koutoku Aihara; Shun'ichi Kuroda; Norihiro Kanayama; Shogo Matsuyama; Katsuyuki Tanizawa; Masato Horie
Journal:  Brain Res Mol Brain Res       Date:  2003-08-19

10.  NELL2 promotes motor and sensory neuron differentiation and stimulates mitogenesis in DRG in vivo.

Authors:  Branden R Nelson; Karen Claes; Valerie Todd; Marta Chaverra; Frances Lefcort
Journal:  Dev Biol       Date:  2004-06-15       Impact factor: 3.582

View more
  23 in total

1.  Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases.

Authors:  Ellen H van den Bogaard; Geuranne S Tjabringa; Irma Joosten; Mieke Vonk-Bergers; Esther van Rijssen; Henk J Tijssen; Mirthe Erkens; Joost Schalkwijk; Hans J P M Koenen
Journal:  J Invest Dermatol       Date:  2013-10-11       Impact factor: 8.551

2.  Alterations in Epidermal Eicosanoid Metabolism Contribute to Inflammation and Impaired Late Differentiation in FLG-Mutated Atopic Dermatitis.

Authors:  Stefan Blunder; Ralph Rühl; Verena Moosbrugger-Martinz; Christine Krimmel; Anita Geisler; Huiting Zhu; Debra Crumrine; Peter M Elias; Robert Gruber; Matthias Schmuth; Sandrine Dubrac
Journal:  J Invest Dermatol       Date:  2016-10-26       Impact factor: 8.551

3.  Generation and Culturing of Primary Human Keratinocytes from Adult Skin.

Authors:  Claus Johansen
Journal:  J Vis Exp       Date:  2017-12-22       Impact factor: 1.355

4.  Rho kinase inhibitor Y-27632 prolongs the life span of adult human keratinocytes, enhances skin equivalent development, and facilitates lentiviral transduction.

Authors:  Ellen H van den Bogaard; Diana Rodijk-Olthuis; Patrick A M Jansen; Ivonne M J J van Vlijmen-Willems; Piet E van Erp; Irma Joosten; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  Tissue Eng Part A       Date:  2012-06-05       Impact factor: 3.845

5.  Th2 Cytokines and Atopic Dermatitis.

Authors:  Eric B Brandt; Umasundari Sivaprasad
Journal:  J Clin Cell Immunol       Date:  2011-08-10

6.  Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis.

Authors:  Ellen H van den Bogaard; Judith G M Bergboer; Mieke Vonk-Bergers; Ivonne M J J van Vlijmen-Willems; Stanleyson V Hato; Pieter G M van der Valk; Jens Michael Schröder; Irma Joosten; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

7.  Antipruritic Effect of Acupuncture in Patients with Atopic Dermatitis: Feasibility Study Protocol for a Randomised, Sham-Controlled Trial.

Authors:  Yu-Kang Kim; Mijung Yeom; SeHyun Kang; Hi-Joon Park; Kyuseok Kim; Hyangsook Lee
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-14       Impact factor: 2.629

Review 8.  Models in the Research Process of Psoriasis.

Authors:  Katarzyna Bocheńska; Elwira Smolińska; Marta Moskot; Joanna Jakóbkiewicz-Banecka; Magdalena Gabig-Cimińska
Journal:  Int J Mol Sci       Date:  2017-11-24       Impact factor: 5.923

9.  Dissociated human dermal papilla cells induce hair follicle neogenesis in grafted dermal-epidermal composites.

Authors:  Rajesh L Thangapazham; Peter Klover; Ji-An Wang; Ying Zheng; Amanda Devine; Shaowei Li; Leonard Sperling; George Cotsarelis; Thomas N Darling
Journal:  J Invest Dermatol       Date:  2013-08-07       Impact factor: 8.551

Review 10.  Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis.

Authors:  Olabola Awosika; Lori Kim; Momina Mazhar; Monica Rengifo-Pardo; Alison Ehrlich
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.